Inmuno-oncología de los Síndromes Mielodisplásicos - page 32

CAR-T cells en enfermedades hematológicas.

ALL: 90% eficacia (Ag: CD19)

Linfoma: 50% eficacia, (Ag: CD19)

Mieloma múltiple, (Ag: BCMA)

Leucemia mielogénica aguda, (Ag: Lewis Y)

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,22,23,24,25,26,27,28,29,30,31 33,34,35,36,37,38,39,40,41,42,...52